Form 4 for WHWK Whitehawk Therapeutics, Inc.
Accepted 2026-04-08 20:32:58 ET · period of report 2026-04-06 · accession 0001995275-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-04-08 20:32 | 2026-04-06+ | WHWK | Lennon David James | CEO, Dir | S - Sale | $3.45 | -260.4K | 533.1K | -33% | -$899.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-06 | S | D | 102,395 | $3.51 | 691,154 | D | — | — | (F1) Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units. |
| 2 | Common | Common Stock | 2026-04-07 | S | D | 94,087 | $3.43 | 597,067 | D | — | — | (F1) Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units. |
| 3 | Common | Common Stock | 2026-04-08 | S | D | 63,945 | $3.40 | 533,122 | D | — | — | (F1) Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units. |